Riskpilot← Back to searchSign inGet full accessB. Science Global ApS
APSBankruptCVR 37588865Bavnevej 20Manufacture of medical and dental instruments and supplies · NACE 3250Est. 20163 employeeswww.bscienceglobal.com
Revenue 2024
DKK -1,7M
-4% vs 2023
EBITDA margin
189.3%
-41% vs 2023
Equity ratio
79.0%
Financial strength
Net profit 2024
DKK -3,3M
+2% vs 2023
| Revenue | DKK -1,7M | -4% |
| EBITDA | DKK -3,3M | -41% |
| Net profit | DKK -3,3M | +2% |
| Total assets | DKK 8,7M | -28% |
| Equity | DKK 6,9M | +210% |
| Employees | 3 | — |
Legal name
B. Science Global ApS
CVR number
37588865
Legal form
Anpartsselskab
NACE code
3250 · Manufacture of medical and dental instruments and supplies
Founded
4. april 2016
Share capital
DKK 550.000
Employees
3 (FTE)
VAT registered
No
Audit selected
Yes
Last report
2024-06-30
Financial year
January – December
Signatory rights
Selskabet tegnes af direktøren eller af den samlede direktion i forening
Company purpose
Selskabets formål er at fremstille og markedsføre hospitals- og laboratorieudstyr, samt anden ifølge direktionens skøn i forbindelse dermed stående virksomhed.
Address
Bavnevej 20
Email
info@bscienceglobal.com
Website
www.bscienceglobal.com
- Event
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | -5 | -658 | -169 | 429 | 354 | 750 | -660 | -1.809 | -1.740 |
| Staff expenses | -93 | -116 | -172 | -142 | -892 | -801 | -307 | -523 | -775 |
| EBITDA | -97 | -774 | -342 | 287 | -538 | -79 | -975 | -2.341 | -3.293 |
| Depreciation & amort. | -0 | -5 | -97 | -118 | -308 | -224 | -268 | -359 | -179 |
| EBIT | -97 | -779 | -439 | 169 | -847 | -303 | -1.243 | -2.699 | -3.473 |
| Net financials | -2 | -39 | -153 | -148 | -153 | -149 | -491 | -431 | -52 |
| Profit before tax | -99 | -817 | -592 | 21 | -1.000 | -452 | -1.733 | -3.130 | -3.525 |
| Tax | -20 | -176 | -129 | -44 | -200 | -192 | -464 | 208 | -269 |
| Net profit | -79 | -642 | -463 | 65 | -799 | -261 | -1.269 | -3.338 | -3.256 |
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Total assets | 201 | 1.821 | 2.515 | 2.436 | 3.642 | 15.030 | 14.196 | 12.056 | 8.707 |
| Equity | -29 | -671 | -1.134 | -1.069 | -1.368 | -1.629 | -2.898 | -6.236 | 6.881 |
| Long-term debt | 0 | 0 | 1.239 | 30 | 1.249 | 1.583 | 16.002 | 16.380 | 103 |
| Short-term debt | 230 | 2.492 | 2.410 | 3.474 | 3.761 | 15.076 | 1.091 | 1.913 | 1.202 |
| Total debt | 230 | 2.492 | 3.649 | 3.504 | 5.010 | 16.658 | 17.094 | 18.292 | 1.305 |
EBITDA margin
-329347100.0%
This company
15.8%
Market median
-2084475416% vs market
20162024
Equity ratio
79.0%
This company
38.2%
Market median
+107% vs market
20162024
Return on equity
-47.3%
This company
18.4%
Market median
-357% vs market
20162024
Net profit margin
-325623700.0%
This company
8.1%
Market median
-4020045779% vs market
20162024
Asset turnover
-0.20×
This company
1.12×
Market median
-118% vs market
20162024
Debt / equity
0.27×
This company
0.62×
Market median
+56% vs market
20162024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-06-30
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-04-04 – 2016-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
BK Founder | Founder | 2016 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2019 | — | — | |
| Board of Directors | 2019 | — | — | |
| Board of Directors | 2024 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
IMB Jutland ApS | Company | 100.0% | 100.0% | 2024 |
2RS1 Holding ApS | Company | 50.0% | 50.0% | 2024 |
Maarssø Invest ApS | Company | 10.0% | 10.0% | 2019 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
IMB Jutland ApS
B. Science Global ApS Board members of B. Science Global ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Bayram Kizil | Founder | 0 companies |
| Søren Maarssø | Chairman | 0 companies |
| Lars Rold Thorsen | Board of Directors | 0 companies |
| Lars Frøvang Thomsen | Board of Directors | 0 companies |